We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
VCYT

Price
44.01
Stock movement up
+3.16 (7.74%)
Company name
Veracyte Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
3.48B
Ent value
3.27B
Price/Sales
8.18
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
28.76
PEG
-
EPS growth
-
1 year return
12.41%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-21

DIVIDENDS

VCYT does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF52.61
Price to FCF61.60
Price to EBITDA86.66
EV to EBITDA81.54

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales8.18
Price to Book-
EV to Sales7.70

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count79.05M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)1.53

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash315.57M
Net receivables47.83M
Total current assets449.22M
Goodwill767.15M
Intangible assets92.48M
Property, plant and equipment0.00
Total assets1.37B
Accounts payable5.51M
Short/Current long term debt40.45M
Total current liabilities72.15M
Total liabilities110.12M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open41.04
Daily high44.42
Daily low40.64
Daily Volume1.18M
All-time high81.38
1y analyst estimate44.10
Beta1.86
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
VCYTS&P500
Current price drop from All-time high-45.92%-4.13%
Highest price drop-71.70%-19.00%
Date of highest drop21 Jul 20258 Apr 2025
Avg drop from high-58.30%-2.73%
Avg time to new high-6 days
Max time to new high282 days89 days
COMPANY DETAILS
VCYT (Veracyte Inc) company logo
Marketcap
3.48B
Marketcap category
Mid-cap
Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Employees
824
SEC filings
CEO
Bonnie H. Anderson
Country
USA
City
South San Francisco
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...